ArticlebioRxiv : the preprint server for biology2025
Knockout of P2Y12 receptor facilitates microglia-neuron body-to-body interactions and accelerates prion disease.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
8 authors.
Funding
Abstract
Microglia continuously monitor neuronal health through somatic purinergic junctions, where microglial processes establish dynamic contacts with neuronal cell bodies. The P2Y12 receptor is a key component of these junctions, essential for intercellular communication between ramified microglia and neurons under homeostatic conditions. While P2Y12 has long been considered a marker of homeostatic microglia, its potential role in reactive microglia during neurodegenerative disease remains largely unexplored. In this study, we demonstrate that P2Y12 deletion significantly reduces microglia-neuron process-to-body contacts in adult mice, consistent with previous findings. However, unexpectedly, P2Y12 loss markedly increases microglia-neuron body-to-body contacts, revealing an alternative mode of microglia-neuron communication independent of P2Y12. In prion-infected mice, P2Y12 expression persists in reactive, amoeboid microglia during advanced disease stages, including those engaging in extensive neuronal envelopment. Notably, P2Y12 loss increases the prevalence of envelopment events and accelerates disease progression. These findings redefine the role of P2Y12 in neurodegeneration, suggesting that its progressive decline lowers the threshold for microglia-neuron body-to-body interactions, ultimately influencing disease trajectory.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.